Target Name: MIR194-2HG
NCBI ID: G105369343
Other Name(s): MIR194-2 host gene | MIR194-2HG variant 1 | MIR194-2 host gene, transcript variant 1

MIR194-2HG: A Potential Drug Target and Biomarker

Mir194-2HG, also known as MIR194-2, is a protein that is expressed in human tissues and has been identified as a potential drug target and biomarker. The protein is located on the surface of certain immune cells, including natural killer cells (NK cells), and has been shown to play a role in the regulation of immune responses and cancer progression.

Recent studies have suggested that MIR194-2HG may be a useful drug target for the treatment of various diseases, including cancer, autoimmune disorders, and infections. This is because the protein is involved in a number of important cellular processes that are involved in the development and progression of these diseases.

One of the potential benefits of targeting MIR194-2HG is that it has been shown to be highly expressed in a variety of cancer types, including breast, lung, and ovarian cancer. This suggests that targeting the protein may be a effective way to treat these cancers, particularly in cases where traditional treatments have become ineffective.

In addition, MIR194-2HG has been shown to play a role in the regulation of immune responses. This is important because many diseases, including cancer, are caused by the immune system getting abnormally active or failing to work properly. By targeting MIR194-2HG, researchers may be able to develop new treatments for these diseases.

Another potential benefit of targeting MIR194-2HG is that it has been shown to be involved in a number of important cellular processes that are involved in the development and progression of autoimmune disorders. These disorders can cause a range of symptoms, including fatigue, joint pain, and inflammation, and can be difficult to treat. By targeting MIR194-2HG, researchers may be able to develop new treatments for these disorders.

In addition, MIR194-2HG has been shown to play a role in the regulation of cell signaling pathways that are involved in the development and progression of a variety of diseases, including cancer. By targeting the protein, researchers may be able to develop new treatments for these diseases.

Overall, MIR194-2HG is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of the protein in these processes and to develop new treatments based on its properties.

Protein Name: MIR194-2 Host Gene

More Common Targets

MIR195 | MIR196A1 | MIR196A2 | MIR196B | MIR197 | MIR1972-1 | MIR1972-2 | MIR1973 | MIR1976 | MIR198 | MIR199A1 | MIR199A2 | MIR199B | MIR19A | MIR19B1 | MIR19B2 | MIR200A | MIR200B | MIR200C | MIR200CHG | MIR202 | MIR202HG | MIR203A | MIR203B | MIR204 | MIR205 | MIR2052 | MIR2052HG | MIR2053 | MIR2054 | MIR205HG | MIR206 | MIR208A | MIR208B | MIR20A | MIR20B | MIR21 | MIR210 | MIR210HG | MIR211 | MIR2110 | MIR2113 | MIR2114 | MIR2115 | MIR2116 | MIR2117 | MIR212 | MIR214 | MIR215 | MIR216A | MIR216B | MIR217 | MIR217HG | MIR218-1 | MIR218-2 | MIR219A1 | MIR219A2 | MIR219B | MIR22 | MIR221 | MIR222 | MIR223 | MIR224 | MIR2276 | MIR2277 | MIR2278 | MIR22HG | MIR2355 | MIR2392 | MIR23A | MIR23AHG | MIR23B | MIR23C | MIR24-1 | MIR24-2 | MIR2467 | MIR25 | MIR2681 | MIR2682 | MIR26A1 | MIR26A2 | MIR26B | MIR27A | MIR27B | MIR28 | MIR2861 | MIR2909 | MIR296 | MIR297 | MIR298 | MIR299 | MIR29A | MIR29B1 | MIR29B2 | MIR29B2CHG | MIR29C | MIR300 | MIR301A | MIR301B | MIR302A